Hims & Hers, Grindr, and RFK Jr. 2-19-25

In this episode, Scott Becker discusses the skyrocketing success of Hims & Hers compared to the stagnant performance of Grindr, and also critiques RFK Jr.’s controversial stance on banning pharmaceutical advertising, arguing its implications on free speech.
3 Quick Notes 2-19-25

In this episode, Scott Becker discusses Medtronic’s recent market hit, the importance of returning to fundamentals when facing challenges, and how setting clear decision-making principles can help manage time and energy effectively.
Oscar Health, Intel, Walgreens & More 2-19-25

In this episode, Scott Becker covers key market shifts.
5 Stories We Are Following Today 2-19-25

In this episode, Scott Becker breaks down five key stories shaping the business world today.
Investing in the Future of Small Business: Jon Staenberg on Search Funds & Entrepreneurship 2-18-25

In this episode, Jon Staenberg, Founder & CEO of Agate Hound Fund, discusses his journey in venture capital, the rise of search funds, and how his fund is transforming small business acquisitions.
Last Year’s Losers, Today’s Winners: Intel & Walgreens Rebound 2-18-25

In this episode, Scott Becker discusses the surprising turnaround of Intel and Walgreens.
Back to the Basics When You’re Struggling 2-18-25

In this episode, Scott Becker explores the importance of getting back to the basics when life feels off track—whether in business, investments, fitness, or relationships.
The Art of Saying No: How to Say “No” to Invitations 2-18-25

In this episode, Scott Becker shares six key strategies for managing invitations, speaking engagements, and networking requests.
8 Stories We Are Following in the Business World Today 2-18-25

In this episode, Scott Becker covers eight key business news stories.
Entrepreneurship, Healthcare, and Capitalism with Dutch Rojas of Physician Capital, Inc. 2-17-25

In this episode, Scott Becker speaks with Dutch Rojas, Founder & CEO of Physician Capital, Inc. Dutch shares his journey in healthcare entrepreneurship, his passion for price transparency, and his work in helping physicians build equity through innovative financial strategies.